Clinical Experience of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients Aged 60 Years and Older in South Korea-Reference-Cited by-同舟云学术

Clinical Experience of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients Aged 60 Years and Older in South Korea

Published:2023 Issue:2 Volume:64 Page:123
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Ji Young Sok¹^ORCID,Ahn Jae-Sook²^ORCID,Yun Jina¹^ORCID,Jang Geum Ha¹^ORCID,Lim Sung Hee¹^ORCID,Kim Se Hyung¹^ORCID,Kim Chan Kyu¹^ORCID,Won Jong Ho³^ORCID,Park Seong Kyu¹^ORCID

Affiliation:

1. Division of Hemato-Oncology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

2. Division of Hematology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea.

3. Division of Hemato-Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.

Funder

Soonchunhyang University

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://eymj.org/pdf/10.3349/ymj.2022.0331

Reference19 articles.

1. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly

2. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations

3. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

4. Allogeneic Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

5. Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia